DGAP-News: Pacific Biosciences Names TSMC Supplier of the Year

        Print
| Source: EQS Group AG
Pacific Biosciences of California, Inc. 

29.01.2013 13:30
---------------------------------------------------------------------------

MENLO PARK, Calif., 2013-01-29 13:30 CET (GLOBE NEWSWIRE) --
Pacific Biosciences of California, Inc., (Nasdaq:PACB), provider of the
PacBio(r) 
RS High Resolution Genetic Analyzer, today recognized TSMC, the world's largest
and premier dedicated semiconductor foundry as its 'Supplier of the Year' for
2012. TSMC is on the leading edge of semiconductor wafer processing and has
been a trusted collaborator of Pacific Biosciences, manufacturing the key
component of its proprietary SMRT(r) Cells for DNA sequencing on the PacBio RS
system. 

'TSMC was selected as a premier supplier of Pacific Biosciences because of
their extensive engineering experience, technological insight and exceptional
level of service,' said Michael Hunkapiller, Ph.D., President and Chief
Executive Officer of Pacific Biosciences. 'In 2012, their joint engineering
efforts along with their commercial flexibility resulted in significant
performance and yield improvements of our SMRT Cells. With TSMC's continued
support, we have just launched the SMRT Cell V3, which provides equivalent
sequencing performance with less library input required.' 

The Supplier of the Year award program recognizes suppliers partnering with
Pacific Biosciences for continuously evolving its core technologies while
promoting efficiency and creating value. 

About Pacific Biosciences

Pacific Biosciences of California, Inc. (Nasdaq:PACB) offers the PacBio(r) RS
High Resolution Genetic Analyzer to help scientists solve genetically complex
problems. Based on its novel Single Molecule, Real-Time (SMRT(r)) technology,
the 
company's products enable: targeted sequencing to more comprehensively
characterize genetic variations; de novo genome assembly to more fully
identify, annotate and decipher genomic structures; and DNA base modification
identification to help characterize epigenetic regulation and DNA damage. By
providing access to information that was previously inaccessible, Pacific
Biosciences enables scientists to increase their understanding of biological
systems. 


         CONTACT: Media:
         Maurissa Messier
         For Pacific Biosciences
         760.539.7417
         maurissa@bioscribe.com
         
         Investors:
         Trevin Rard
         Pacific Biosciences
         650.521.8450
         ir@pacificbiosciences.com
News Source: NASDAQ OMX



29.01.2013 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Pacific Biosciences of California, Inc.
              
               
              United States
Phone:        
Fax:          
E-mail:       
Internet:     
WKN:          
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------